Although ERs (oestrogen receptors) mediate breast tumour behaviour, the precise role of ERβ remains unclear. This is mainly because analyses have been complicated by the presence in breast tissue of three ERβ protein variants (ERβ1, ERβ2 and ERβ5) that derive from differential 3 splicing. We have recently identified the first known mechanisms responsible for the differential control of isoform expression, involving regulation of translation via 5 -UTRs (untranslated regions). In the present study, we have uncovered further complexity involving the influence of multiple promoters and cross-talk between 5 -and 3 -UTRs. We demonstrate that full-length ERβ mRNAs are transcribed from three separate promoters; two promoters are wellestablished within the literature, whereas the third represents a novel finding. Each promoter produces transcripts with distinct 5 -UTRs. The differential 3 splicing that produces transcripts coding for the ERβ isoforms also defines isoform-specific 3 -UTRs. We identified exact 3 -UTR sequences for each isoform, and have shown that alternative polyadenylation sites are used in a cell-type specific manner to produce transcripts with 3 -UTRs of different lengths. Critically, we show that 5 -and 3 -UTRs combine to specify the efficiencies with which individual transcripts are translated, with 3 -UTR length having a key influence. In addition, we demonstrate how 17β-oestradiol, a key driver of breast cancer development, affects the regulation of ERβ expression at both transcriptional and translational levels.
INTRODUCTION
ERs (oestrogen receptors) are critical mediators of oestrogen function and play roles in many pathological processes, especially carcinogenesis [1] . Although the roles of ERα are relatively well understood, those of ERβ remain unclear. This is due, in part, to a reported discrepancy between ERβ expression at mRNA and protein levels, leading to conflicting expression data [2, 3] . Also, ERβ is expressed as at least five protein isoforms, derived from differential 3 splicing of ERβ transcripts [4] , yet their potential to have distinct functions has often been ignored in favour of analysis of total ERβ. In breast tissue, ERβ1, ERβ2 and ERβ5 predominate, with each appearing to have separate biological functions as demonstrated by their associations with different breast cancer types and prognoses [5] [6] [7] [8] . Differences between the isoforms are also evident in terms of comparisons of expression in normal breast tissue and breast cancer. ERβ1 is frequently down-regulated in cancer compared with normal cells [9, 10] , suggesting that it may function as a tumour suppressor [11] [12] [13] . However, ERβ2 appears to be up-regulated during carcinogenesis [10, 14] , whereas ERβ5 may also be up-regulated, at least at the level of mRNA [15] . Little is known about the mechanisms responsible for these changes in ERβ expression. ERβ promoter methylation has frequently been observed in breast cancers, and this is thought to be responsible for down-regulation of some ERβ transcripts, although this appears to be at odds with the reported up-regulation of ERβ2 and ERβ5. We have recently identified the first known mechanisms responsible for differential control of expression of the different isoforms involving regulation of translation via two alternative 5 -UTRs (untranslated regions) [16] . We have now extended this theme to examine thoroughly the regulatory functions of the extensive range of ERβ UTRs, and have determined further mechanisms for differential control of ERβ isoform expression.
EXPERIMENTAL Cell culture, transfection, flow cytometry and dual luciferase assays
Cell lines representing breast cancers of luminal (MCF7) and basal (MDAMB-231) subtypes and benign non-transformed breast tissue (HB2) were obtained from the European Collection of Animal Cell Cultures. Cells were cultured in RPMI 1640 medium containing 5 % (v/v) FBS (fetal bovine serum) (MCF7, MDAMB-231) or DMEM (Dulbecco's modified Eagle's medium) containing or 10 % (v/v) FBS (HB2) (both Invitrogen) at 37
• C under 5 % CO 2 . Bi-monthly mycoplasma checks (MycoAlert ® Mycoplasma detection assay, Lonza) were consistently negative and STR (short tandem repeat) profiles confirmed cell identity. Cells were transfected as described previously [16] . For experiments using exogenous E2 (17β-oestradiol), cells were cultured in Phenol Red-free medium (Invitrogen) supplemented with charcoal-stripped FBS. At 5 h post-transfection, fresh medium or medium containing 10 nM E2 (Sigma-Aldrich) was added before analysis after 24 h. For flow cytometry, cells were removed from wells with trypsin and resuspended in fresh medium containing 1 % (v/v) serum. GFP (green fluorescent protein) expression was quantified (mean fluorescent intensity of 10 cells were defined as expressing GFP. Dual-luciferase assays (Promega) were performed according to the manufacturer's instructions using a Lumat LB9507 luminometer (Berthold Technologies). pSV40-Renilla (Promega) was used as a control.
Plasmid construction
pTH-GFPa and GFP reporters for UTRa and UTRc have been described previously [16, 17] . The GFP reporter for the E1 5 -UTR was cloned similarly to those for UTRa and UTRc; the UTR was amplified by PCR from cDNA prepared from MCF7 cells and was cloned upstream of the GFP ORF (open reading frame) in pTH-GFPa. Importantly, this strategy removes the 5 end of the multiple cloning site, allowing the inserted 5 -UTRs to be immediately adjacent to the transcriptional start site. 3 -UTRs were amplified by PCR from cDNA prepared from HB2 cells and were cloned downstream of the GFP ORF in each of the 5 -UTR reporter constructs with BamHI/HindIII. Promoter sequences were amplified from MCF7 genomic DNA and cloned into pGL3-Basic (Promega) using KpnI/NheI. The E1 promoter was cloned as two fragments: a 3 fragment cloned using KpnI/NheI, then a 5 fragment cloned using KpnI. Primer sequences are listed in Supplementary Table S1 at http://www.BiochemJ.org/bj/429/bj4290283add.htm.
cDNA synthesis and PCR
RNA was purified from cells with RNeasy kits (Qiagen); contaminating DNA was removed with Turbo DNase I (Applied Biosystems). First-strand cDNA was synthesized using SuperScript II (according to the manufacturer's protocol) and oligo(dT) or random hexamers. Triplicate real-time PCR analysis was performed (Applied Biosystems SYBR ® Green PCR Master Mix and 7900HT machine). Dissociation curves and serial cDNA dilutions were performed to ensure primer specificities and equivalent amplification efficiencies; correlation coefficients of >0.985 and primer efficiencies of >95 % and <100 % were deemed acceptable. Reactions were also performed using template lacking RT (reverse transcriptase): products were either undetectable or greatly reduced (>30000-fold less product than the equivalent RT+), hence genomic or plasmid DNA contamination was not considered to interfere with data. Expression of UTRs was determined relative to expression of the RPLP0 (36B4) gene [18] . RACE (rapid amplification of cDNA ends) was performed using 5 RACE System 2 or 3 RACE System (both Invitrogen) according to the manufacturer's instructions (both standard and a modified adapter primer were used for ERβ2 3 RACE). All primer sequences are listed in Supplementary Table  S1 . Products were analysed on 2.5 % agarose gels [0.5 μg/ml ethidium bromide, 1 × TBE (45 mM Tris/borate and 1 mM EDTA)] and visualized on an UV transilluminator. Products were excised from gels and cloned into pGEM-Teasy (Promega); at least five clones for each were sequenced. Note that products are larger than the UTRs they represent since they include some reading frame and the RACE adapters.
RNA structure and statistical analyses
Modelling was performed using mfold v3.1 to predict potential secondary structures for RNA molecules as described previously [16] . The algorithm finds base-pairing solutions that are sterically possible and release the greatest amount of free energy ( G) during structural folding; more stable structures release more energy as they form and therefore have greater G values [19] . Student's t test was used for statistical analysis using Microsoft Excel. All P values were two-sided; P < 0.05 was considered significant.
RESULTS

A novel 5 -UTR for ERβ
We studied previously the regulatory roles of two ERβ 5 -UTRs that we termed UTRa and UTRc [16] . These 5 -UTRs result from transcription initiation from two alternative promoters and mutually exclusive splicing of the untranslated first exons, exon 0K or 0N, to the first coding exon (exon 1) [20] . 5 -RACE analyses were performed in breast cell lines in order to examine ERβ 5 -UTRs further. Products representing 5 -UTRs containing only sequence from exon 1 or from immediately upstream of the 5 splice site of exon 1 were the sole products obtained from primers located within the coding region of exon 1 ( Figure 1A) . UTRa or UTRc could only be detected by 5 -RACE using primers specific for their respective upstream exons, 0K and 0N [16] . RACE products containing only sequence from within the accepted bounds of exon 1 could be interpreted in two ways: as truncated versions of UTRa or UTRc, or as complete 5 -UTRs derived from transcriptional initiation within exon 1. Products containing sequence upstream of the accepted bounds of exon 1 were likely to result from transcriptional initiation adjacent to exon 1. Figure 1 (B) shows an alignment of mRNAs containing UTRa, UTRc or the novel shorter 5 -UTR ('UTR-E1') with the 5 end of the human ERβ gene (esr2) on 14q23. The diagram depicts putative transcriptional initiation (bent black arrows) over a range of sequences upstream of and within exon 1 allowing the expression of a 5 extension to exon 1 (grey box) on some UTR-E1-containing transcripts. We next performed qPCR (quantitative PCR) to examine the relative expression of UTRa, UTRc and UTR-E1 in breast cell lines. We analysed expression of UTR-E1 using a primer that was complementary to the sequence within this 5 extension of exon 1, and was therefore not contained within UTRa or UTRc. It is worth noting that these analyses may under-represent UTR-E1 expression, since RACE analyses show that the 5 extension of exon 1 is present on only a subset of UTR-E1-containing transcripts. All three breast cell lines examined expressed UTR-E1 ( Figure 1C ). Products were not amplified from mock reverse transcription reactions, providing validation that transcribed/reversetranscribed sequences were detected rather than contaminating genomic DNA. In HB2 and MCF7 cells, UTRa was the majority species, with UTRc and UTR-E1 being expressed at similar lesser levels. In contrast, MDAMB-231 cells expressed ∼ 12.5-fold more UTRc, and ∼ 3.5-fold more UTR-E1, than UTRa. We concluded that UTR-E1 represented a novel 5 -UTR for ERβ.
A third transcriptional promoter for ERβ
Next, our hypothesis was that the DNA immediately upstream of exon 1 acts as a promoter allowing expression of transcripts containing UTR-E1. We cloned ∼ 2 kb of the genomic DNA directly upstream of exons 0K, 0N or E1 into separate luciferase reporter vectors and performed luciferase assays in HB2 and MCF7 breast cell lines in order to examine the relative promoter activities of the two known ERβ promoters and the putative third promoter. Activities are shown in each cell type ( Figure 2 ). The putative third promoter ('promoter E1') showed activity in both cell lines. In HB2 cells, promoter E1 showed intermediate activity between promoters 0N, the most active, and 0K, the least active. In MCF7 cells, promoters 0K and 0N determined similar transcriptional activities, whereas promoter E1 was ∼ 70 % weaker. We concluded that ERβ transcription is indeed driven Approx. 2 kb of genomic DNA directly upstream of exons 0K, 0N or E1 was cloned into luciferase reporter vectors. HB2 and MCF7 cell lines were transiently transfected with equal copy numbers of luciferase reporter lacking additional promoter sequences (empty) or containing promoter sequences as shown, and luciferase assays were performed after 24 h. A minimum of two independent experiments were performed, and within each experiment three technical replicates were included. Results are means + − S.D. of technical triplicates within a representative experiment.
by a third, previously uncharacterized, promoter that determines the expression of UTR-E1.
-UTRs differentially regulate efficiency of ERβ translation
We have shown previously that UTRa and UTRc have profound and differential influences on ERβ translation. We hypothesized that UTR-E1 may also influence translation, thus we extended our previous analyses to test this using our established GFP reporter assay [16, 21] . UTRa, UTRc and UTR-E1 were cloned upstream of the GFP reading frame in expression vectors. For UTR-E1, we cloned the sequence encoded by the published extent of exon 1, representing a commonly identified 5 -RACE product. Cells were transiently transfected with equal numbers of copies of vectors to allow expression of GFP mRNAs either with non-regulatory 5 -UTRs (positive control; 'con'), or with UTRa, UTRc or UTR-E1. GFP protein expression was measured by flow cytometry, and GFP mRNA expression was measured by qPCR allowing determination of relative translational efficiencies for each GFP mRNA ( Figure 3 ). As published previously [16] , UTRa and UTRc inhibited translation, with UTRa being strikingly inhibitory in nature. UTR-E1 was also inhibitory in nature despite being short (only 90 nucleotides; as compared with UTRa, 289 nucleotides, and UTRc, 418 nucleotides) and having a very low predicted degree of secondary structure [as assessed by the theoretical change in free energy of folding, G; UTR-E1's predicted G is −14 kcal/mol (1 kcal = 4.184 kJ), whereas, for comparison, those Reporters were constructed to express mRNAs containing the GFP reading frame preceded by different 5 -UTRs: a control (con) sequence lacking regulatory motifs, UTRa, UTRc or UTR-E1. Cell lines were transiently transfected with equal copy numbers of either control or experimental constructs. GFP protein and mRNA were quantified by flow cytometry and real-time PCR respectively. Translational efficiency (protein synthesized per unit of mRNA) is presented relative to the GFP control that lacks a specialized 5 -UTR. A minimum of two independent experiments were performed and within each experiment three technical replicates were included. Results are means + − S.D. of technical triplicates within a representative experiment.
of UTRa and UTRc are −84 and −166 kcal/mol]. A consistent pattern of relative influences for each UTR was seen in all cell lines, with UTRa being more, and UTR-E1 less, inhibitory. We concluded that ERβ 5 -UTRs specified the efficiencies with which downstream ORFs are translated. We also noted that promoter E1 may be especially important in terms of defining ERβ function, since transcripts from this promoter, which contain UTR-E1, are the most efficiently translated ERβ mRNAs.
Cross-talk between 5 -and 3 -UTRs influences translation of individual ERβ isoforms
Transcripts for at least three functionally distinct ERβ isoforms are produced in breast cells [15] . These are derived from differential 3 splicing of the final ERβ exons [4] . It is evident that this differential splicing must also confer different 3 -UTRs on transcripts for each isoform, although the exact 3 -UTR sequences are poorly defined, especially with respect to which potential polyadenylation sites are used. We were interested to examine whether ERβ 3 -UTRs might influence translation. First, we performed 3 -RACE analyses for each isoform in HB2 and MCF7 breast cells to identify 3 -UTR sequences ( Figure 4A ). For ERβ1, we were only able to amplify a product in MCF7 cells, probably because ERβ1 expression levels were low in HB2 cells. 3 -UTR. The longer ERβ2 3 -UTR ('β2-long') was, in fact, expressed in both cell lines ( Figure 4A ; right-hand panel). These data are summarized in Figure 4 (B) in the form of an alignment of the 3 ends of mRNAs for each isoform with the 3 end of the human ERβ gene. We were interested to examine whether these isoform-specific 3 -UTRs define different translational efficiencies in conjunction with the 5 -UTRs, thereby allowing differential expression of the isoforms. We cloned 3 -UTRs downstream of the GFP reading frame in each 5 -UTR GFP reporter construct. For ERβ2, we focused on comparison of β2-long, as detected by specific PCR, with the sequences identified using RACE ('β2-short'; we examined a 120 nucleotide sequence, GenBank ® accession number AF051428). For ERβ5, we examined both sequences identified by RACE ('β5 HB' and 'β5 MCF'). HB2 and MCF7 cells were transiently transfected with equal numbers of copies of vectors to allow expression of GFP mRNAs with non-regulatory UTRs (positive control; 'con'), or with reporters for each isoformspecific 3 -UTR in combination with each 5 -UTR. Translational efficiencies were determined as described above and are presented relative to positive controls ( Figure 5 . We concluded that cross-talk between 5 -and 3 -UTRs had profound influences on the translational efficiency of transcripts for individual ERβ isoforms, with length of 3 -UTRs, as defined by differential use of polyadenylation sites, being a critical factor in determining the outcome.
E2 modifies ERβ transcription and translation
E2 influences the downstream effects of ERs by binding to and modifying their activity as transcription factors. It has also been reported that E2 has an impact on expression of ERβ itself at both transcriptional [22, 23] and translational [24] levels by largely unknown mechanisms. We next investigated the influence of E2 on ERβ transcription and translation using our reporters for both of these regulatory stages. Cells were transfected with equal copy numbers of either luciferase reporters containing different ERβ promoters (as in Figure 2 ) or GFP reporters containing isoform-specific UTR pairings (as in Figure 5 ) for analysis of influences on transcription and translation respectively. Cells were then treated with vehicle or E2 for 24 h and were
Figure 6 E2 modifies ERβ transcription
HB2 and MCF7 cells were transfected with equal copy numbers of luciferase reporters containing different ERβ promoters (as in Figure 2 ). Cells were treated with vehicle (white bars) or 10 nM E2 (black bars) for 24 h, and luciferase assays were performed. E2 caused an increase in the activity of promoter 0K in MCF7 cells, but not in HB2 cells (A), whereas it had no significant effect on promoters 0N or E1 (B and C). A minimum of two independent experiments were performed and within each experiment three technical replicates were included. Results are means + − S.D. of technical triplicates within a representative experiment.
analysed for luciferase activity or translational efficiency of GFP transcripts. In terms of transcriptional activity, E2 caused a 1.6-fold activation of the 0K promoter in MCF7 cells (P = 0.001), but not in HB2 cells (Figure 6A ), while having no significant effect on promoters 0N or E1 (Figures 6B and 6C) . Effects of E2 on translational efficiencies specified by the various UTR pairings were more complex. Translation of transcripts containing the ERβ1 3 -UTR were increased by E2 when combined with UTRc or UTR-E1 ( Figure 7A ; P = 0.008 and 0.03 respectively). ERβ2 3 -UTRs (both short and long) specified an E2-dependent decrease in translational efficiency when paired with 5 -UTRa ( Figure 7B ; both P = 0.003), but an increase when paired with UTR-E1 (P = 0.01 and 0.049 respectively). ERβ5 3 -UTRs also specified differential responses to E2, determining both decreases (β5 MCF paired with UTR-E1; P = 0.005) and increases in MCF7 cells were transfected with equal copy numbers of GFP reporters containing UTR pairings (as in Figure 5 ). Cells were treated with vehicle (white bars) or 10 nM E2 (black bars) for 24 h, and translational efficiency of GFP transcripts was determined. A minimum of two independent experiments were performed, and within each experiment three technical replicates were included. Results are means + − S.D. of technical triplicates within a representative experiment.
translation (β5 HB paired with UTRc; P = 0.002). We concluded that E2 has only relatively weak influences on ERβ transcription and translation. However, as these influences act differentially on the promoters and on the isoform-specific UTR pairings, these weak influences cumulatively have potential to modify the balance of ERβ isoforms.
DISCUSSION
It is well established that the ERβ gene has two promoters allowing the expression of full-length transcripts, promoters 0K and 0N [20] . mRNAs transcribed from each promoter have different 5 -UTRs, termed UTRa and UTRc [16] ( Figure 1B) . However, full-length ERβ transcripts containing neither of these UTRs have been reported [25] , and the presence of an additional promoter, giving rise to further alternative 5 -UTRs, has long been suspected [26] . We have identified an additional 5 -UTR, UTR-E1, and the corresponding novel promoter region, promoter E1 (Figures 1 and 2) . A number of previous studies have attempted to assess the relative transcriptional strengths and thereby the importance of promoters 0K and 0N [27, 28] . However, our previous data, demonstrating that ERβ 5 -UTRs determine differential and cell-type-specific translational inhibition [16] , cast doubt on these assessments. Reporter assays including exonic sequences would combine translational differences with the expected measure of transcription. We have therefore investigated promoter activities of only sequences immediately upstream of the exons thereby avoiding translational regulatory motifs (although risking failure to include important transcription-factor-binding sites within the exons), and have analysed translational regulation separately. We found promoter 0N to be the most active in both cell lines tested, although promoters E1 and 0K are also active ( Figure 2 ). Methylation of CpG islands within promoter 0N has been reported in cancers, including those of the breast [29] , ovary [30] and prostate [28] , and this is thought to be responsible for down-regulation of some forms of ERβ during carcinogenesis [9, 10, 31] . In this context, it is interesting to note the presence of a CpG island within promoter E1 (from −2180 to −1878 with respect to the translational start site); our preliminary data suggest that these sequences are also commonly methylated in breast cancers [32] . It is also interesting that the relative activities of the promoters as determined by luciferase assay (Figure 2 ) do not correlate with the expression of the 5 -UTRs derived from the endogenous promoters ( Figure 1C ). This may relate to the inhibitory methylation of endogenous promoters, or to the influence of transcription factors binding outside the sequence included in the reporter constructs. We demonstrated previously that ERβ expression is regulated at the level of translation, with UTRa and UTRc having potent and differential influences [16] . When these analyses were extended to include UTR-E1, we found that UTR-E1 allowed the most efficient translation of the ERβ 5 -UTRs (Figure 3 ). Therefore transcripts from promoter E1, which contain UTR-E1, are likely to contribute disproportionally to ERβ protein levels. Moreover, a key finding of the present study is that translational regulation acts differentially on transcripts for the ERβ isoforms 1, 2 and 5. These transcripts are derived from differential 3 splicing [4] , giving them isoform-specific 3 -UTRs. We identified 3 -UTR sequences for each isoform (Figure 4 ) and demonstrated that, when combined with ERβ 5 -UTRs, these specified a wide range of translational efficiencies ( Figure 5 ). Most striking was the ability of different ERβ2 3 -UTRs to define up to a 10-fold difference in translational efficiency when paired with UTRa. 5 -UTRa inhibits translation on account of inefficient translational scanning induced by secondary structure and initiation at uORFs (upstream ORFs) [16] . The shorter ERβ2 3 -UTR (β2-short) overcame this inhibitory influence, whereas the longer form (β2-long), which included the entire sequence of β2-short, had little effect. Regulatory elements in both 5 -and 3 -UTRs have important roles in determining translational efficiencies, facilitated by transcript circularization induced by interaction of poly(A)-binding protein binding at the 3 end of transcripts with eIF4G (eukaryotic initiation factor 4G) at 5 ends [33, 34] . β2-short apparently interacted with 5 -UTRa, resulting in a loss of inhibitory structures and/or uORF translation, whereas the same sequences were unable to interact in this way in the context of β2-long. Therefore differential use of polyadenylation sites, defining 3 -UTR length, exerts translational control. It is interesting that faster-proliferating cells and cancer cells preferentially use proximal polyadenylation sites [35, 36] ; in the case of ERβ2, this would lead to increased translation that may explain how ERβ2 is up-regulated in breast cancer cells [10, 14] despite promoter methylation and down-regulation of ERβ transcripts [29, 37] . Shortening of 3 -UTRs has been associated with increased protein expression for a number of cancer-related genes [36] . For these genes, this resulted from increased mRNA stability and/or loss of microRNA-mediated translational repression when compared with their longer 3 -UTRs. For ERβ2, this is clearly not the case, since β2-short dominantly derepressed the influence of 5 -UTRa, as opposed to merely lacking repressive 3 elements present in β2-long. ERβ5 3 -UTRs also tended to specify relatively efficient translation, but, in this case, only when modifying the influences of 5 -UTRc or UTR-E1. In MCF7 cells, this was only apparent for the ERβ5 3 -UTR that was actually cloned from these cells. As for ERβ2, the data do not support a simple model of shorter 3 -UTRs having fewer repressive elements, since both lengths of ERβ5 3 -UTR acted to derepress the influences of inhibitory 5 -UTRs.
Finally, we investigated influences of the ER ligand E2 on transcriptional activity of ERβ promoters and translation specified by ERβ UTRs. We found E2 exerted relatively mild, although statistically significant, influences at multiple levels, with potential to change the balance of ERβ isoform expression. Unfortunately, we were unable to confirm whether this balance is altered, since quantitative detection of endogenous ERβ protein isoforms in cell lines is unreliable with the antibodies currently available. First, we found E2 induced transcription in MCF7 cells only with the 0K promoter ( Figure 6 ), a promoter we have shown previously to exhibit a relative preference for producing ERβ1 and ERβ5 transcripts in this cell type [16] . Secondly, we found E2 induced a wide range of changes in translational efficiencies of transcripts with ERβ UTR pairs ( Figure 7) ; the overall effect in any cell type would be defined by the relative proportions of each UTR pairing within the total pool of transcripts for that isoform. E2 is known to modulate levels of microRNAs [38, 39] , thus these constitute potential mediators of its influence on ERβ translational efficiencies. Indeed, we have found that miR-92 can regulate expression of ERβ1 acting at its 3 -UTR [40] . However, we find that different UTR pairs respond differently, therefore we infer that accessibility of individual microRNA-binding sites in the context of interactions between 5 -and 3 -UTRs would influence whether particular transcripts respond to changes in levels of any particular microRNA.
In conclusion, we have revealed novel mechanisms controlling ERβ expression that help explain the reported lack of concordance between ERβ mRNA and protein levels, and the differential expression of ERβ1, ERβ2 and ERβ5, and give new insights into the regulation of ER function. To the best of our knowledge, this is the first time cross-talk between multiple 5 -and 3 -UTRs has been implicated in the differential regulation of translation of different protein isoforms from one gene, demonstrating how the ERβ gene provides a model for study of complex gene regulatory pathways. 
AUTHOR CONTRIBUTION
